Laser Treatment Can Be First Choice for Glaucoma 

Researchers reporting in The Lancet on the LiGHT Study concluded that a change in the clinical practice pattern of how we treat glaucoma should be implemented so that glaucoma laser treatment was a first choice treatment, rather than eye drops which is the typical approach to glaucoma treatment. The LiGHT Study compared eye drops to glaucoma Selective Laser Trabeculoplasty (SLT) treatment in terms of lowering intraocular pressure, health related quality of life, cost and cost effectiveness. The data was gathered and analyzed and concluded that Selective Laser Trabeculoplasty (SLT) should be offered as a first-line treatment for open angle glaucoma and ocular hypertension, supporting a change in clinical practice.

If you or someone you know is at risk for glaucoma, has ocular hypertension or is being treated for glaucoma, please be certain you have regular eye exams with glaucoma testing to prevent vision loss. Ask your eye doctor about treatment options such as SLT for glaucoma when you schedule your exam at Matossian Eye Associates in Pennington, NJ at 609-882-8833, Hamilton, NJ at 609-890-0772 or Doylestown, PA at 215-230-9200, or visit Matossian Eye Associates or Facebook. 

Matossian Eye Associates is a multispecialty eye care center staffed by a team of ophthalmologist & optometrist eye doctors and retina specialists, cataract specialists, glaucoma specialists & eye plastic surgery specialists with office locations in Two Capital Way, Suite 326, Pennington, NJ 08534-609-882-8833, 1445 Whitehorse-Mercerville Road, Suite 106, Hamilton, NJ 08619-609-890-0772, 501 Hyde Park, Route 202, Doylestown, PA 18902-215-230-9200, an affiliate of Prism Vision Group.